These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 19086243)

  • 1. Rotavirus vaccines.
    Vesikari T
    Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
    Vesikari T; Itzler R; Karvonen A; Korhonen T; Van Damme P; Behre U; Bona G; Gothefors L; Heaton PM; Dallas M; Goveia MG
    Vaccine; 2009 Dec; 28(2):345-51. PubMed ID: 19879226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
    Nakagomi T; Nakagomi O
    Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: recent developments and future considerations.
    Angel J; Franco MA; Greenberg HB
    Nat Rev Microbiol; 2007 Jul; 5(7):529-39. PubMed ID: 17571094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RotaTeq: a new oral rotavirus vaccine.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):61-3. PubMed ID: 16874281
    [No Abstract]   [Full Text] [Related]  

  • 10. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
    Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
    Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
    Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants.
    Bernstein DI; Sack DA; Reisinger K; Rothstein E; Ward RL
    J Infect Dis; 2002 Nov; 186(10):1487-9. PubMed ID: 12404166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.